The Benefits of Cryptolepis: A Complete Guide to the Antimicrobial Botanical
A West African medicinal plant that's become one of the most-studied botanicals in modern Lyme and co-infection protocols
Cryptolepis sanguinolenta is a climbing vine native to West Africa, used in traditional medicine across Ghana, Nigeria, and surrounding countries for centuries. Originally most known for treating malaria, it has become — in the last two decades — one of the most-studied antimicrobial botanicals in modern Lyme medicine. Research demonstrates strong activity against persistent forms of Borrelia (the bacteria that causes Lyme disease) and against Babesia, one of the most common Lyme co-infections.
This guide covers what Cryptolepis is, the traditional and modern uses, the active compounds that drive its effects, how it compares to other antimicrobial botanicals, and the difference between whole-herb and concentrated extract preparations.
Cryptolepis sits at the intersection of West African herbal tradition and modern Lyme research — a centuries-old remedy that turned out to have measurable activity against some of the most persistent pathogens in tick-borne illness.
What Is Cryptolepis?
Cryptolepis sanguinolenta (common name "Ghana quinine" or "yellow-dye root") is a climbing vine in the periwinkle family. The root and stems are the medicinal parts — they produce a distinctive bright yellow extract when prepared. In traditional West African medicine, Cryptolepis has been used for centuries to treat:
- Malaria (where it has documented antiprotozoal activity)
- Urinary tract infections
- Upper respiratory infections
- Various febrile illnesses
- Hypertension and circulatory complaints
The active compounds — cryptolepine and a family of related indoloquinoline alkaloids — give it both its color and its biological activity. Cryptolepine has been the subject of substantial pharmaceutical research, including for antimalarial drug development.
The Modern Use Case: Lyme and Co-Infections
Beginning in the early 2000s, Lyme-literate physicians and researchers began exploring Cryptolepis as part of botanical protocols for chronic Lyme disease — particularly for cases that hadn't fully resolved with conventional antibiotic treatment. The interest grew significantly after a 2020 Johns Hopkins study identified Cryptolepis as one of the most effective botanicals tested against stationary-phase (persister) forms of Borrelia burgdorferi — the bacterial forms that resist standard antibiotic protocols.
Today, Cryptolepis is widely used in Lyme medicine for several specific situations:
- Babesia support — Cryptolepis is one of the most commonly used botanicals for Babesia, a malaria-like parasite that often co-infects with Lyme
- Persistent Borrelia — for cases where standard antibiotic protocols haven't fully resolved symptoms
- Foundational antimicrobial support — often paired with other antimicrobial herbs (Japanese Knotweed, Cat's Claw, Andrographis) in comprehensive Lyme protocols
- Long-term immune and microbial balance — for the maintenance phase of recovery
How Cryptolepis Works
The mechanisms behind Cryptolepis's antimicrobial activity involve several different pathways:
- DNA intercalation. Cryptolepine binds to bacterial DNA, disrupting replication. This is similar to how some pharmaceutical antibiotics work but through a slightly different mechanism.
- Biofilm disruption. Borrelia can form biofilms — protective communities that shield bacteria from both antibiotics and the immune system. Cryptolepis has demonstrated activity against these biofilm forms.
- Persister cell activity. The Johns Hopkins research showed Cryptolepis was effective against the "persister" cells of Borrelia — dormant forms that survive standard antibiotic treatment and contribute to chronic Lyme symptoms.
- Multi-target action. Unlike single-target pharmaceutical antibiotics, Cryptolepis works through multiple mechanisms simultaneously, which appears to reduce the likelihood of bacterial adaptation.
This multi-pathway action is part of why Cryptolepis remains effective in cases where antibiotics alone haven't fully resolved infection. It's also why it tends to be used in combination with other antimicrobial botanicals — multiple compounds, multiple mechanisms, broader coverage.
Cryptolepis Synergy vs Cryptolepis Concentrate: Two Preparations
Cryptolepis comes in two preparations that serve different purposes:
Whole-Herb (Synergy)
Whole-herb Cryptolepis preparations include the full plant matrix — cryptolepine plus all the supporting compounds (other alkaloids, polyphenols, glycosides) that nature combines in the plant. The advantages:
- Gentler on the system; better tolerated for sensitive individuals
- Broader spectrum action from the full compound profile
- Well-suited for foundational use, long-term protocols, or early protocol phases
- Often combined with supportive botanicals (as in Cryptolepis Synergy) that complement the antimicrobial action with immune and circulatory support
Concentrated Extract (Concentrate)
Extract preparations concentrate the active compounds, providing higher per-capsule potency. The advantages:
- Higher per-dose levels of active compounds (cryptolepine and supporting alkaloids)
- More targeted action for higher-demand protocol phases
- Often used in practitioner-guided protocols for chronic Lyme or active co-infection management
- Cryptolepis Concentrate combines the concentrated extract with carefully selected supporting compounds for targeted use
Many practitioners use both — Synergy for foundational and longer-term use, Concentrate for more targeted phases. The right choice depends on individual tolerance, the phase of recovery, and practitioner guidance.
Cryptolepis Synergy
Cryptolepis Synergy combines whole-herb Cryptolepis sanguinolenta with nine supporting botanicals that promote microbial balance, immune steadiness, circulation, and broader system resilience — ten synergistic botanicals working together for a gentler, foundational approach. Built for daily, long-term use as part of structured microbial and immune support.
See the complete formula →Cryptolepis Concentrate
Cryptolepis Concentrate delivers a more concentrated extract of Cryptolepis alongside seven complementary botanicals — eight targeted compounds providing higher per-dose levels of active alkaloids for more demanding protocol phases. Designed for practitioner-guided use during periods requiring more intensive antimicrobial support.
See the complete formula →Important: Cryptolepis is a potent botanical with measurable pharmacological activity — it should not be combined with prescription medications without practitioner guidance. Pregnant or nursing women should not use Cryptolepis. For Lyme disease, co-infections, or any chronic illness, work with a qualified healthcare provider familiar with botanical medicine and tick-borne illness.
Frequently Asked Questions
What is Cryptolepis used for?
Research, particularly the 2020 Johns Hopkins study on persister forms of Borrelia, has expanded interest in Cryptolepis as a foundational antimicrobial botanical for Lyme medicine.
How does Cryptolepis compare to antibiotics?
Cryptolepis has demonstrated activity against forms of Borrelia (persisters, biofilms) that resist standard antibiotic protocols. It's also broader-spectrum and gentler on the microbiome than typical antibiotics. That said, it isn't a substitute for antibiotic treatment in acute Lyme disease — early antibiotic intervention remains the standard of care.
What's the difference between Cryptolepis Synergy and Cryptolepis Concentrate?
Cryptolepis Concentrate uses a more concentrated extract of the active compounds, alongside seven targeted supporting botanicals. It provides higher per-dose levels of cryptolepine and related alkaloids — designed for more demanding protocol phases under practitioner guidance.
Many practitioners use both, choosing based on the phase of recovery and individual tolerance.
Is Cryptolepis safe to take long-term?
It should not be used during pregnancy or nursing, can interact with certain medications (particularly those affecting blood sugar or blood pressure), and should be used cautiously in people with serious cardiovascular conditions. Work with a healthcare provider familiar with botanical medicine for any extended use.
How long does it take to see results from Cryptolepis?
In Lyme protocols, Cryptolepis is rarely used as a single intervention — it's typically combined with other antimicrobial botanicals and supportive compounds, with the full protocol producing changes over several months. Drainage support, binders, and inflammation balance work alongside the antimicrobial action.
Can I take Cryptolepis without a practitioner?
Lyme medicine requires individualized adjustment — knowing when to cycle compounds, when to escalate or de-escalate, how to manage Herxheimer reactions, and how Cryptolepis fits into the broader protocol. A practitioner experienced in tick-borne illness can do this in ways self-directed use can't.